pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health131
viewlistcards
  • Preclinical
    LXM-2
    Diabetes Laxxon Medical GmbH
  • Preclinical
    LXP-103
    Obesity LaunXP Biomedical Co Ltd
  • Phase 2
    LXP-109
    Non-Small Cell Lung Cancer LaunXP Biomedical Co Ltd
  • Phase 2
← prev
page 120 of 271
next →
Pain89
Neurology1
LXP-5268
Triple-Negative Breast Cancer (TNBC)
LaunXP Biomedical Co Ltd
  • LYBALVI
    LYBALVI (OLANZAPINE)
    1 INDICATIONS AND USAGE LYBALVI is indicated for the trea…$ALKS Alkermes plc.
  • Phase 2
    LYGLIV-0001
    Liver Diseases LyGenesis Inc
  • Phase 1
    LYL-273
    Metastatic Colorectal Cancer$LYEL Lyell Immunopharma, Inc.
  • LYNAVOY
    LYNAVOY (LINERIXIBAT)
    no indication GlaxoSmithKline LLC
  • Phase 2
    LYT-200
    Liver Cancer Gallop Oncology Inc
  • LYTGOBI
    LYTGOBI (FUTIBATINIB)
    no indication Taiho Oncology Inc
  • Phase 1
    LZ-001
    Non-Small Cell Lung Cancer Livzon Pharmaceutical Group Inc
  • Marketed
    Labetalol Hydrochloride Hikma
    Labetalol Hydrochloride
    Hypertension Hikma Pharmaceuticals USA Inc
  • pre_registration
    Lagevrio
    Lagevrio (molnupiravir)
    Coronavirus Disease 2019 (COVID-19)$MRK Merck & Co., Inc.
  • Marketed
    Lanreotide Acetate Cipla
    Lanreotide Acetate
    Acromegaly InvaGen Pharmaceuticals Inc
  • Marketed
    Larotid
    Amoxil (amoxicillin)
    Bacterial Vaginosis GlaxoSmithKline LLC
  • Preclinical
    Lead Candidate
    Parkinson's Disease MaavRx Ltd
  • Preclinical
    Lead Program
    Corneal Degeneration 2A Biosciences Inc
  • Marketed
    Lemtrada
    Lemtrada (alemtuzumab)
    Relapsing Remitting Multiple Sclerosis (RRMS) Genzyme Corp
  • Marketed
    Leucovorin Calcium Teva
    Leucovorin Calcium
    Megaloblastic Anemia Teva Pharmaceuticals USA Inc
  • Marketed
    Levolet
    Levolet (levothyroxine sodium)
    Goiter Genus Lifesciences Inc
  • Marketed
    Levoxyl
    Levoxyl (levothyroxine sodium)
    Goiter$PFE PFIZER INC
  • Marketed
    Lexapro
    Lexapro (escitalopram oxalate)
    Generalized Anxiety Disorder (GAD)$ABBV AbbVie Inc.
  • Marketed
    Lialda ER
    Lialda (mesalamine)
    Ulcerative Colitis Takeda Pharmaceuticals USA Inc
  • Marketed
    Linisol
    Lidocaine Hydrochloride
    Local Anesthetic Effect B. Braun Medical Inc
  • pre_registration
    LipidRescue
    Drug Toxicity ResQ Pharma Inc
  • Marketed
    Lipitor
    Lipitor (atorvastatin calcium)
    Cardiovascular Risk Factors$VTRS Viatris Inc
  • Marketed
    Lodoco
    Lodoco (colchicine)
    Cardiovascular Risk Factors Agepha Pharma sro
  • Marketed
    Loestrin
    Taytulla ((ethinylestradiol + norethindrone))
    Female Contraception Allergan Sales LLC
  • Marketed
    Lomotil
    Lomotil ((atropine sulfate + diphenoxylate [INN]))
    Diarrhea$PFE PFIZER INC
  • Marketed
    Loperamide Hydrochloride Bionpharma
    Loperamide Hydrochloride
    Diarrhea Bionpharma Inc